Seattle-based Cardeas Pharma just raised a lot more cash to fight a big problem that hospitals wrestle with every day, and which they’d rather not say much about publicly. Cardeas, the startup led by prolific drug developer Bruce Montgomery, has raised...
smile
frown
skip
Seattle-based Kineta has found some more support for its drug development work from an unlikely source—a group of oil traders. The company said today it has raised an undisclosed amount of cash from Hydra, a group made up of 13 recently retired oil...
smile
frown
skip
NanoString Technologies just started selling its first diagnostic test after 10 years in business, and now it’s getting ready for another milestone—an initial public offering. The Seattle-based company said today that it is seeking to raise as much...
smile
frown
skip